Search company, investor...

Predict your next investment

Corporation
chinacdc.com

Investments

34

Partners & Customers

1

About Xiamen C&D

Xiamen C&D (SHA: 600153) is a modern service-oriented enterprise with supply chain operation and real estate development as its main businesses.

Headquarters Location

43F, C&D International Building No.1699 Huandao East Road

Xiamen, Fujian, 361008,

China

+86-592-2263333

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Xiamen C&D News

Qiming-backed specialty hospital chain Bang-Er Orthopaedic bags nearly $110m in pre-IPO round

Nov 10, 2023

09 November, 2023 Bang-Er Orthopaedic, which invests in and operates a orthopaedic hospital chain, has snapped over 800 million yuan ($109.8 million) in a pre-IPO funding round led by state-affiliated Xiamen C&D Emerging Industry Equity Investment. The round roped in local investment firms including Lake Bleu Capital, October Capital, and GY Capital as participating investors, while two Hong Kong-listed insurers including Sunshine Insurance Group and China Pacific Insurance Company also joined the round via their subsidiaries, according to a company release on Thursday. The proceeds will help the hospital chain accelerate its digital transformation, expand its market presence in China, and ramp up hires, among others. Bang-Er Orthopaedic, which also goes by its legal name Zhejiang Boner Medical Investment Management, currently oversees 17 medical facilities, with 16 of those set up according to Grade II and III hospital standards. China’s hospitals can be classified into a three-tier system — Grade I hospitals are community health centres that offer medical care, prevention, and rehabilitation services, while Grade II hospitals are mostly regional or district-level medical facilities that provide comprehensive medical services. Grade III, or the tertiary hospitals, offers high-level and specialised medical services. With over 20 years of history, the Hangzhou-registered firm bagged 300 million yuan ($46 million) in a Series D funding round joined by Fortune Capital and Cenova Capital. It also counts Qiming Venture Partners, Eight Roads Ventures China, and GP Capital, among some of its backers.

Xiamen C&D Investments

34 Investments

Xiamen C&D has made 34 investments. Their latest investment was in Cencorp Automation as part of their Series B on October 10, 2023.

CBI Logo

Xiamen C&D Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/27/2023

Series B

Cencorp Automation

$13.67M

Yes

2

9/1/2023

Series B

Supmea

Yes

2

8/14/2023

Series C

Litecore

Yes

2

6/20/2023

Series A

Subscribe to see more

Subscribe to see more

10

2/27/2023

Series A - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/27/2023

9/1/2023

8/14/2023

6/20/2023

2/27/2023

Round

Series B

Series B

Series C

Series A

Series A - III

Company

Cencorp Automation

Supmea

Litecore

Subscribe to see more

Subscribe to see more

Amount

$13.67M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

2

2

10

10

Xiamen C&D Acquisitions

1 Acquisition

Xiamen C&D acquired 1 company. Their latest acquisition was Mango TV on September 29, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/29/2017

Other

$99M

$1,334M

Acquired

4

Date

9/29/2017

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

$1,334M

Note

Acquired

Sources

4

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.